End stage renal disease
Conditions
Interventions
Kidney for transplantation procured from marginal donor graft is preserved by machine perfusion system. Kidney is preserved after procurement by simple storage in donor hospital ,then, trans
Sponsors
Asahikawa Medical University
Tokyo medical university hachioji medical center Toranomon hospital Tohoku university Fujita health university Asahikawa medical university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: kidney graft is selected by Japanese Organ Transolant Network Among kidney graft, marginal donor graft is used for this study under the criteria of United Nation Organ Sharing in USA 1)Donor age morethan 60Y/O 2)Donor age morethan 50y/o and death b cerebro-cardiavascular disease, hypertension or serum Cr more than 1.5 mg/dl 3) Death after cardiac death donor
Exclusion criteria
Exclusion criteria: Exclusion criteria 1;Disease 1) Severe heart, liver disease 2) Active infection 3) Malignant disease 4) Others by professional judgement by Medical Dr 2) Female; Pregnant male; having baby until 3 months after transplantation 3) Under 18 Y/oat the time of transplantation 4) Simutaneous pancreas and kidney transplantation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major endopoints The stability of flow, perfusion pressure and temparature during perfusion preservation for two hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Post op. HD days, Frequency of required post op HD Post op Cr(mg/dl) | — |
Countries
Japan
Contacts
Public ContactNaoto Matsuno
Asahikawa Medical Unievrsity Hepato-Biliary- Pancreas surgery & Transplantation
Outcome results
None listed